Home > Analytics > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 524412     NSE : AAREYDRUGS    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Feb 04,2026
Price(EOD): ₹ 63.05
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 179.06 Cr
Value of ₹ 1 Lac invested in AAREY DRUGS & PHARMACEUTICALS
on Feb 04,2021 (price: ₹ 27.20)

₹ 1 L

₹ 2.32 L

1W : -9.4% 1M : -1.9% 1Y : 41.7%
AD     Remove this Ad
Industry Peers & Returns1W1M1Y
AAREY DRUGS & PHARMACEUTICALS -9.4% -1.9% 41.7%
SUN PHARMACEUTICAL INDUSTRIES 7.1% -1.5% -6.2%
DIVIS LABORATORIES 2.8% -2.8% 6%
CIPLA 0.2% -12.5% -7.9%
TORRENT PHARMACEUTICALS 3.1% 4.2% 18.8%
DR REDDYS LABORATORIES 2.2% -1.6% 0%
MANKIND PHARMA 2.6% -2.1% -16.6%
ZYDUS LIFESCIENCES 1.4% -1.5% -5.7%
LUPIN 2.6% 3.8% 2.9%

FUNDAMENTAL ANALYSIS OF AAREY DRUGS & PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Sep2025, Y: Mar2025
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]



VALUATION OF AAREY DRUGS & PHARMACEUTICALS

 
Valuation Score
[As on : Feb 04,2026 ]

Ratio Standalone
P/E
P/B
P/S
49.88
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 3.58 Cr
[Latest Qtr - Sep2025 - Standalone Results ]

1.31
P/B Calculated based on Book Value of Rs 135.97 Cr
[Latest Year - Mar2025 - Standalone Results ]

0.42
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2025 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 73% undervalued companies ! Discover More →

FAIR VALUE OF AAREY DRUGS & PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
4372%
173%
186%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF AAREY DRUGS & PHARMACEUTICALS



AAREY DRUGS & PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF AAREY DRUGS & PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2025
2024
2023
Avg_3yrs
0.26
0.24
0.33
0.28
-
-
-
-
[Last Annual Data : Mar2025]
Financial Ratios →

PLEDGED PROMOTER SHARES OF AAREY DRUGS & PHARMACEUTICALS

Pledged Promoter Shares
0 %
As on : Dec2025

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF AAREY DRUGS & PHARMACEUTICALS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-17.66%
55.29%
-14.18%
-25.24%
-19.96%
-29.05%
-15.06%
-35.78%
QtrlyTrend
-6
Latest Qtr: Sep2025
Quarterly Result Analysis →


AAREY DRUGS & PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about AAREY DRUGS & PHARMACEUTICALS


Is AAREY DRUGS & PHARMACEUTICALS good for long term investment?

As on Feb 04,2026, the Fundamentals of AAREY DRUGS & PHARMACEUTICALS look Poor and hence it may not be good for long term investment ! See Financial Performance of AAREY DRUGS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is AAREY DRUGS & PHARMACEUTICALS UnderValued or OverValued?

As on Feb 04,2026, AAREY DRUGS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS ?

As on Feb 04,2026, the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS is Rs. 22.07 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 1.41
Fair Value [Median EV / Sales Model] : Rs. 23.13
Fair Value [Median Price / Sales Model] : Rs. 22.07
Estimated Median Fair Value of AAREY DRUGS & PHARMACEUTICALS : Rs. 22.07

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is AAREY DRUGS & PHARMACEUTICALS trading at a Premium or Discount?

As on Feb 04,2026, AAREY DRUGS & PHARMACEUTICALS is trading at a Premium of 186% based on the estimates of Median Intrinsic Value!